ID   PRKRA_RAT               Reviewed;         313 AA.
AC   Q4V8C7;
DT   21-FEB-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2005, sequence version 1.
DT   02-OCT-2024, entry version 109.
DE   RecName: Full=Interferon-inducible double-stranded RNA-dependent protein kinase activator A;
DE   AltName: Full=Protein activator of the interferon-induced protein kinase;
DE   AltName: Full=Protein kinase, interferon-inducible double-stranded RNA-dependent activator;
GN   Name=Prkra;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16396499; DOI=10.1021/pr0503073;
RA   Moser K., White F.M.;
RT   "Phosphoproteomic analysis of rat liver by high capacity IMAC and LC-
RT   MS/MS.";
RL   J. Proteome Res. 5:98-104(2006).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18 AND SER-167, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Activates EIF2AK2/PKR in the absence of double-stranded RNA
CC       (dsRNA), leading to phosphorylation of EIF2S1/EFI2-alpha and inhibition
CC       of translation and induction of apoptosis. Required for siRNA
CC       production by DICER1 and for subsequent siRNA-mediated post-
CC       transcriptional gene silencing. Does not seem to be required for
CC       processing of pre-miRNA to miRNA by DICER1. Promotes UBC9-p53/TP53
CC       association, sumoylation and phosphorylation of p53/TP53 at 'Lys-386'
CC       at 'Ser-392' respectively and enhances its activity in a EIF2AK2/PKR-
CC       dependent manner (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer. Interacts with EIF2AK2/PKR through its DRBM
CC       domains. Interacts with DICER1, AGO2 and TARBP2. Also able to interact
CC       with dsRNA (By similarity). Interacts with UBC9 (By similarity). Forms
CC       a complex with UBC9 and p53/TP53 (By similarity). Interacts with DUS2L
CC       (via DRBM domain) (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000250}.
CC       Cytoplasm {ECO:0000250}.
CC   -!- DOMAIN: Self-association may occur via interactions between DRBM
CC       domains as follows: DRBM 1/DRBM 1, DRBM 1/DRBM 2, DRBM 2/DRBM 2 or DRBM
CC       3/DRBM3. {ECO:0000250}.
CC   -!- PTM: Phosphorylated at Ser-246 in unstressed cells and at Ser-287 in
CC       stressed cells. Phosphorylation at Ser-246 appears to be a prerequisite
CC       for subsequent phosphorylation at Ser-287. Phosphorylation at Ser-246
CC       and Ser-287 are necessary for activation of EIF2AK2/PKR under
CC       conditions of stress (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the PRKRA family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC097446; AAH97446.1; -; mRNA.
DR   RefSeq; NP_001019951.1; NM_001024780.1.
DR   AlphaFoldDB; Q4V8C7; -.
DR   SMR; Q4V8C7; -.
DR   STRING; 10116.ENSRNOP00000015624; -.
DR   iPTMnet; Q4V8C7; -.
DR   PhosphoSitePlus; Q4V8C7; -.
DR   jPOST; Q4V8C7; -.
DR   PaxDb; 10116-ENSRNOP00000015624; -.
DR   GeneID; 311130; -.
DR   KEGG; rno:311130; -.
DR   UCSC; RGD:1306707; rat.
DR   AGR; RGD:1306707; -.
DR   CTD; 8575; -.
DR   RGD; 1306707; Prkra.
DR   eggNOG; KOG3732; Eukaryota.
DR   InParanoid; Q4V8C7; -.
DR   OrthoDB; 3130057at2759; -.
DR   PhylomeDB; Q4V8C7; -.
DR   Reactome; R-RNO-203927; MicroRNA (miRNA) biogenesis.
DR   Reactome; R-RNO-426486; Small interfering RNA (siRNA) biogenesis.
DR   Reactome; R-RNO-9833482; PKR-mediated signaling.
DR   PRO; PR:Q4V8C7; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016442; C:RISC complex; IBA:GO_Central.
DR   GO; GO:0070578; C:RISC-loading complex; ISO:RGD.
DR   GO; GO:0003725; F:double-stranded RNA binding; ISO:RGD.
DR   GO; GO:0019899; F:enzyme binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0070883; F:pre-miRNA binding; ISO:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0030295; F:protein kinase activator activity; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0035197; F:siRNA binding; IBA:GO_Central.
DR   GO; GO:0140374; P:antiviral innate immune response; ISO:RGD.
DR   GO; GO:0034599; P:cellular response to oxidative stress; ISO:RGD.
DR   GO; GO:0043583; P:ear development; ISO:RGD.
DR   GO; GO:0042474; P:middle ear morphogenesis; ISO:RGD.
DR   GO; GO:0035196; P:miRNA processing; ISO:RGD.
DR   GO; GO:0042473; P:outer ear morphogenesis; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:RGD.
DR   GO; GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0031054; P:pre-miRNA processing; ISO:RGD.
DR   GO; GO:0050821; P:protein stabilization; ISO:RGD.
DR   GO; GO:0070920; P:regulation of regulatory ncRNA processing; IBA:GO_Central.
DR   GO; GO:0070922; P:RISC complex assembly; ISO:RGD.
DR   GO; GO:0030422; P:siRNA processing; ISS:UniProtKB.
DR   GO; GO:0048705; P:skeletal system morphogenesis; ISO:RGD.
DR   CDD; cd19889; DSRM_PRKRA_rpt1; 1.
DR   CDD; cd19891; DSRM_PRKRA_rpt2; 1.
DR   CDD; cd19892; DSRM_PRKRA_rpt3; 1.
DR   Gene3D; 3.30.160.20; -; 3.
DR   InterPro; IPR014720; dsRBD_dom.
DR   InterPro; IPR044465; PRKRA_DSRM_1.
DR   InterPro; IPR044466; PRKRA_DSRM_2.
DR   InterPro; IPR044467; PRKRA_DSRM_3.
DR   InterPro; IPR051247; RLC_Component.
DR   PANTHER; PTHR46205:SF2; INTERFERON-INDUCIBLE DOUBLE-STRANDED RNA-DEPENDENT PROTEIN KINASE ACTIVATOR A; 1.
DR   PANTHER; PTHR46205; LOQUACIOUS, ISOFORM B; 1.
DR   Pfam; PF00035; dsrm; 2.
DR   SMART; SM00358; DSRM; 3.
DR   SUPFAM; SSF54768; dsRNA-binding domain-like; 3.
DR   PROSITE; PS50137; DS_RBD; 3.
PE   1: Evidence at protein level;
KW   Cytoplasm; Phosphoprotein; Reference proteome; Repeat; RNA-binding;
KW   RNA-mediated gene silencing.
FT   CHAIN           1..313
FT                   /note="Interferon-inducible double-stranded RNA-dependent
FT                   protein kinase activator A"
FT                   /id="PRO_0000223611"
FT   DOMAIN          34..101
FT                   /note="DRBM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00266"
FT   DOMAIN          126..194
FT                   /note="DRBM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00266"
FT   DOMAIN          240..308
FT                   /note="DRBM 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00266"
FT   REGION          1..103
FT                   /note="Sufficient for self-association and interaction with
FT                   TARBP2"
FT                   /evidence="ECO:0000250"
FT   REGION          1..20
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          102..195
FT                   /note="Sufficient for self-association and interaction with
FT                   TARBP2"
FT                   /evidence="ECO:0000250"
FT   REGION          195..313
FT                   /note="Sufficient for self-association and interaction with
FT                   TARBP2"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         18
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         167
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         246
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O75569"
FT   MOD_RES         287
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O75569"
SQ   SEQUENCE   313 AA;  34355 MW;  78550978D5B92043 CRC64;
     MSHSRHRAEA PPLQREDSGT FSLGKMITAK PGKTPIQVLH EYGTKTKNIP VYECERSDVQ
     VHVPTFTFRV TVGDITCTGE GTSKKLAKHR AAEAAINILK ANASICFAVP DPLMPDPSKQ
     PKNQLNPIGS LQELAIHHGW RLPEYTLSQE GGPAHKREYT TICRLESFME TGKGASKKQA
     KRNAAEKFLA KFSNISPENH ISLTNVVGHS LGCTWHSLRN SPGEKINLLK RSLLSLPNTD
     YIQLLSEIAK EQGFSITYLD IEELSANGQY QCLAELSTSP ITVCHGSGIS CGNAQSDAAH
     NALQYLKIIA ERK
//
